JNJ vs. ISRG, MRNA, NVAX, ABBV, BRK.B, LLY, MRK, PFE, PG, and XOM
Should you be buying Johnson & Johnson stock or one of its competitors? The main competitors of Johnson & Johnson include Intuitive Surgical (ISRG), Moderna (MRNA), Novavax (NVAX), AbbVie (ABBV), Berkshire Hathaway (BRK.B), Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK), Pfizer (PFE), Procter & Gamble (PG), and Exxon Mobil (XOM).
Johnson & Johnson vs. Its Competitors
Intuitive Surgical (NASDAQ:ISRG) and Johnson & Johnson (NYSE:JNJ) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.
83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 69.6% of Johnson & Johnson shares are held by institutional investors. 0.7% of Intuitive Surgical shares are held by company insiders. Comparatively, 0.2% of Johnson & Johnson shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Intuitive Surgical presently has a consensus target price of $595.95, suggesting a potential upside of 35.08%. Johnson & Johnson has a consensus target price of $176.29, suggesting a potential downside of 0.80%. Given Intuitive Surgical's higher probable upside, research analysts clearly believe Intuitive Surgical is more favorable than Johnson & Johnson.
Intuitive Surgical has a net margin of 28.51% compared to Johnson & Johnson's net margin of 25.00%. Johnson & Johnson's return on equity of 32.49% beat Intuitive Surgical's return on equity.
In the previous week, Johnson & Johnson had 21 more articles in the media than Intuitive Surgical. MarketBeat recorded 57 mentions for Johnson & Johnson and 36 mentions for Intuitive Surgical. Intuitive Surgical's average media sentiment score of 1.38 beat Johnson & Johnson's score of 1.26 indicating that Intuitive Surgical is being referred to more favorably in the media.
Intuitive Surgical has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500. Comparatively, Johnson & Johnson has a beta of 0.4, indicating that its share price is 60% less volatile than the S&P 500.
Johnson & Johnson has higher revenue and earnings than Intuitive Surgical. Johnson & Johnson is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Summary
Intuitive Surgical beats Johnson & Johnson on 9 of the 17 factors compared between the two stocks.
Get Johnson & Johnson News Delivered to You Automatically
Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding JNJ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Johnson & Johnson Competitors List
Related Companies and Tools
This page (NYSE:JNJ) was last updated on 9/3/2025 by MarketBeat.com Staff
